Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer

BACKGROUND: Previous studies have shown that fibrinogen-to-albumin ratio (FAR) is a novel prognostic immune biomarker in various diseases. In this study, we investigated the role of FAR in the prognosis of patients with stage IB-IIA cervical cancer (CC). METHODS: A total of 278 eligible participants...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Qiang, Liu, Wei, Yang, Yujia, Yang, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382827/
https://www.ncbi.nlm.nih.gov/pubmed/32711484
http://dx.doi.org/10.1186/s12885-020-07191-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382827/
https://www.ncbi.nlm.nih.gov/pubmed/32711484
http://dx.doi.org/10.1186/s12885-020-07191-8

Ejemplares similares